Is justified the use of GIK solutions in acute myocardial infarct?

Alfredo de Micheli

2008, Number 3

Next >>

Arch Cardiol Mex 2008; 78 (3)

Is justified the use of GIK solutions in acute myocardial infarct?

Micheli A

Full text

How to cite this article

Language: Spanish
References: 31
Page: 243-246
PDF size: 99.37 Kb.

ABSTRACT

No abstract

REFERENCES

Rogers WJ, Russell Jr RO, Mc Daniel HG, Rackley CE: Effects of glucose-insulin-potassium infusion on myocardial metabolism in man. Am J Cardiol 1977; 40: 421-428.
Rogers WJ, Segall PH, Mc Daniel HG, Mantle JA, Russell Jr RO, Rackley CE: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol 1979; 43: 801-809.
Mantle JA, Rogers WJ, Smith LR, Mc Daniel HG, Papapietro SE, Russell Jr RO, Rackley CE: Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction. Results from a randomized clinical trial. Am Heart J 1981; 102: 313-324.
Taegtmayer H, Goodwin GW, Doenst T, Frazier OH: Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997; 80: 3A-10A.
Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1952-1956.
Díaz R, Paolasso EA, Piegas LS, Tajer CD, Gil Moreno M, Corvalán R, et al: Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: 2227-2234.
Apstein CS: Glucose-insulin-potassium for acute myocardial infarction. Remarkable results from a new prospective, randomized trial. Circulation 1998; 98: 2223-2226.
Sodi Pallares D, de Micheli A: Un tentativo di reintegrazione ionica cellulare in alcune malattie cardiovascolari. Atti Acc Med Lombarda 1962; 17(4): 509-519.
Sodi Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, de Micheli A: Effects of an intravenous infusion of potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962; 9(2): 166-181.
Marano L, Bestetti A, Lomuscio A, Tagliabue L, Castini D, Torricone D, et al: Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol 2000; 55(1): 9-15.
Klein L, van Campen L, Sieswerda GT, Kamp O, Visser CA, Visser FC: Glucose-Insulin-Potassium echocardiography detects improved segmental myocardial function and viable tissue shortly after acute myocardial infarction. J Am Soc Echocardiogr 2006; 19(6): 763-771.
Rasoul S, Ottervanger JP, Trinmer JR, Svilaas T, Henriques JPS, Dambrink J-HE, van der Horst ICC, Zijlstra F: One year outcomes after glucose-insulin-poptassium in ST elevation myocardial infarction: The glucose-insulin-potassium study II (GIPS-II). Int J Cardiol 2007; 122: 52-55.
Metha S R, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, et al: CREATE-ECLA Trial Group Investigators: Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-Segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial. JAMA 2005; 293: 437-446.
Eiferman D, Pérez-Tamayo R A, Abe K, Okum E, Higgins R: Real-time monitoring of cardiac metabolism using biosensors shows myocardial protection during ischemia-reperfusion injury with glucose-insulin-potassium administration. Surgery 2007; 142: 150-155.
Hess ML, Okabe E, Poland J, Werner M, Stewart JA, Greenfield LJ: Glucose-insulin-potassium protection during the course of hypothermic global ischemia and reperfusion; a new proposed mechanism by the scavenging of free radicals. J Cardiovasc Pharmacol 1983; 5: 35-43.
de Micheli A, Medrano GA, Sodi Pallares D: Efectos de algunas soluciones electrolíticas sobre la evolución electrocardiográfica del infarto experimental agudo del miocardio. Arch Inst Cardiol Mex 1963; 39(5): 567-580.
de Micheli A: La terapéutica metabólica con glucosa-insulina-potasio. Bosquejo histórico. Arch Inst Cardiol Mex 2000; 70(6): 609-615.
Su H, Sun X, Ma H, Zhang H-F, Yu D-J, Huang C, et al: Acute hyperglycemia exarcebates myocardial ischemia/reperfusion injury and blunts cardioprotective effects of GIK. Am J Physiol (Endocrinol Metab) 2007; 293: E629-E635.
Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
Hafstad AD, Solevag GH, Severson DL, Larsen T S, Aasum TS: Perfused hearts from type 2 diabetic (db/db) mice show metabolic responsiveness to insulin. Am J Physiol (Heart Circ Physiol) 2006; 290: H1763-H1769.
Hafstad AD, Khalid A M, How O-J, Larsen TS, Aasum E: Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol (Endocrinol Metab) 2007; 292: E1288-1294.
Zarich SW, Nesto RW: Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 2007; 115: e436-e439.
Koskentari JK, Kaukorante PK, Rimpilaine J, Vainionpaa PP, Ontonen PP, Surcel HM, et al: Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 2006; 50: 962-969.
Cherbakoff A, Tojama S, Hamilton WF: Relation between coronary sinus plasma potassium and cardiac arrhythmias. Circ Res 1957; 5: 517-521.
Robertshaw HJ, Hall GM: Diabetes mellitus: anaesthetic management. Anaesthesia 2006; 61: 1187-1190. Erratum 2007; 62: 88-100.
Zhang HX, Zang Y-M, Huo J-H, Liang S J, Zhang H-F, Wang-Y-M, et al: Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs. J Cardiovasc Pharmacol 2006; 48(6): 306-313.
Kloner RA, Nesto RW: Glucose-insulin-potassium for acute myocardial infarction. Continuing controversy over cardioprotection. Circulation 2008; 117(19): 2523-2533.
Opie LH: Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 2008; 117(17): 2172-2177.
Tsang MW, Davidoff R, Kotach A, Apstein CS, Hesselvik JF, Nguyen H, et al: Diastolic dysfunction after coronary artery bypass grafting. The effect of glucose-insulin-potassium infusion. J Card Surg 2007; 22: 185-191.
Guadalajara Boo JF: Entendiendo la insuficiencia cardíaca. Arch Cardiol Mex 2006; 76(4): 431-447.
Lazar HL, ChipkinSR, Fitzgerald CA: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004; 109(12): 1497-1502.